Bone Grafts And Substitutes Market To Reach $5.50 Billion By 2033

Bone Grafts And Substitutes Market Growth & Trends

The global bone grafts and substitutes market size is expected to reach USD 5.50 billion by 2033, registering a CAGR of 5.6% from 2026 to 2033, according to a new report by Grand View Research, Inc. The increasing prevalence of orthopedic disorders and surge in number of orthopedic surgeries are likely to drive the market growth. In addition, technological advancements in developing advanced orthopedic grafts & substitutes and rising investments by leading players to meet increasing global demand for advanced grafts have further escalated the industry expansion.

Increasing demand for developing biocompatible bone grafts to reduce adverse reactions is driving the market. Increasing use of synthetic bone grafts with Hydroxyapatite and Tricalcium Phosphate, which has shown better biocompatibility as compared to others, is fueling the market growth. Market players are continuously developing new products with better biocompatibility, bioactivity, and suitable mechanical properties. For instance, in October 2020, Graftys received Medical Device Single Audit Program (MDSAP) certification for its Sterile Calcium Phosphate Resorbable Bone Void Fillers and related delivery systems in Australia, Brazil, Canada, and U.S. It also received CE recertification in Europe.

The increasing use of bone grafts in density is propelling the growth of dental bone grafts and substitutes market. The bone grafts are mostly used as a scaffold and filler to facilitate bone formation and promote healing. Dental implant surgery has now become very popular with advanced surgical techniques such as bone grafts and bone regeneration. Moreover, increasing demand and success rates of dental implants are fueling market growth. According to the American Academy of Implant Dentistry, as of 2020, the number of people getting dental implants has risen by 500,000 annually. The source also reported a success rate of 95% in the implant dentistry segment. Around 5 million implant procedures are performed in the U.S. every year.

Synthetic bone graft technology is benefiting advanced medicine, but the cost of such technologies is high, thus restraining market growth. The average price of DBM ranges from USD 600 to USD 865; that of bone morphogenetic protein matrix ranges from USD 3,450 to USD 5,000, and of synthetic ceramic & polymer-based bone grafts ranges from USD 893 to USD 2,000. In addition, reimbursement policies vary based on autografts and bone graft substitutes used, which increase the cost of procedures. This helps avoid incisions and difficulty in obtaining donor grafts. Therefore, the high cost of associated devices and technologies may hinder market growth.

 Request a free sample copy or view report summary: Bone Grafts And Substitutes Market Report

Bone Grafts And Substitutes Market Report Highlights

• The allograft segment dominated the market with the largest revenue share of 59.67% in 2025, owing to factors such as biological advantages associated with the allografts and surgical efficiency.

• The spinal fusion segment accounted for the largest revenue share of 60.84% in 2025. A rising number of cases associated with medical conditions such as chronic back pain, scoliosis, and herniated discs has resulted in a growing number of spinal fusion surgeries.

• North America dominated the bone grafts and substitutes market with a revenue share of 41.96% in 2025. The presence of multiple bone grafts and substitute manufacturers in the country, accessibility to sophisticated healthcare infrastructure required for complicated surgeries, and availability of innovative products contribute to the dominance of this regional market.

Bone Grafts And Substitutes Market Segmentation

Grand View Research has segmented the global bone grafts and substitutes market on the basis of material type, application, and region:

Bone Grafts And Substitutes Material Type Outlook (Revenue in USD Million; Unit Volume in Thousand Units, 2021 - 2033)

• Allograft

  • Demineralised Bone Matrix

  • Others

• Synthetic

  • Ceramics

    • HAP

    • ß-TCP

    • α-TCP

    • bi-phasic calcium phosphates (BCP)

    • Others (calcium sulphates, tricalcium phosphate)

  • Composites

  • Polymers

  • Bone Morphogenic Proteins (BMP)

Bone Grafts And Substitutes Application Outlook (Revenue USD Million, 2021 - 2033)

• Craniomaxilofacial

• Dental

• Foot and Ankle

• Joint Reconstruction

• Long Bone

• Spinal Fusion

Bone Grafts And Substitutes Regional Outlook (Revenue in USD Million; Unit Volume in Thousand Units, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Bone Grafts And Substitutes Market

• AlloSource

• DePuy Synthes (Johnson & Johnson)

• Baxter

• NuVasive, Inc.

• Smith + Nephew

• Medtronic

• Orthofix Medical, Inc.

• OST Laboratories

• Zimmer Biomet

• Geistlich Pharma AG

• Stryker

• Biobank